Clostridium difficile infection recurrence

Also known as: Recurrent Clostridium Difficile Infection / Clostridium difficile infection

DrugDrug NameDrug Description
DB13140BezlotoxumabA monoclonal antibody used to reduce the recurrence of Clostridium difficile infections.
DB00507NitazoxanideA thiazolide anti-infective used to treat infections by protozoa, helminths, anaerobic bacteria, microaerophilic bacteria, and viruses.
DB01220RifaximinA rifamycin-based non-systemic antibiotic used for the treatment of gastrointestinal bacterial infections, such as traveler's diarrhea and irritable bowel syndrome, and reduction of overt hepatic encephalopathy recurrence in adults.
DrugDrug NamePhaseStatusCount
DB00512Vancomycin1Completed1
DB00512Vancomycin2Recruiting1
DB00512Vancomycin2Suspended1
DB00512Vancomycin2 / 3Terminated1
DB13140Bezlotoxumab4Not Yet Recruiting1
DB13140Bezlotoxumab4Recruiting1
DB00512Vancomycin4Recruiting2
DB13140BezlotoxumabNot AvailableEnrolling by Invitation1